[{"id":"a03d3af5-bc9a-495c-a3cf-cca5e665a5f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT06082362","created_at":"2023-10-14T01:13:16.661Z","updated_at":"2024-07-02T16:35:33.610Z","phase":"","brief_title":"Personalized Signature of Chronic Inflammation and Early Aging Predictive of the Comorbidities in Infertile Men","source_id_and_acronym":"NCT06082362","lead_sponsor":"IRCCS San Raffaele","biomarkers":" CD8 • CD4 • IL18 • IL1B • NLRP3 • CASP1","pipe":"","alterations":" ","tags":["CD8 • CD4 • IL18 • IL1B • NLRP3 • CASP1"],"overall_status":"Recruiting","enrollment":" Enrollment 350","initiation":"Initiation: 06/21/2023","start_date":" 06/21/2023","primary_txt":" Primary completion: 06/20/2024","primary_completion_date":" 06/20/2024","study_txt":" Completion: 06/20/2025","study_completion_date":" 06/20/2025","last_update_posted":"2023-10-13"},{"id":"c4ec5c4c-4c79-4761-96b6-d089338bc996","acronym":"","url":"https://clinicaltrials.gov/study/NCT06038526","created_at":"2023-09-14T14:13:05.141Z","updated_at":"2024-07-02T16:35:36.912Z","phase":"Phase 2","brief_title":"Evaluation of Canakinumab in High-Risk Former-Smokers","source_id_and_acronym":"NCT06038526","lead_sponsor":"Peter Shields","biomarkers":" IL1B • CASP1","pipe":"","alterations":" ","tags":["IL1B • CASP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Ilaris (canakinumab)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 75","initiation":"Initiation: 09/30/2023","start_date":" 09/30/2023","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-09-14"},{"id":"79ff0d7f-8e12-46e7-a59f-373c976c10bc","acronym":"","url":"https://clinicaltrials.gov/study/NCT05638542","created_at":"2022-12-06T15:57:57.071Z","updated_at":"2024-07-02T16:35:50.646Z","phase":"","brief_title":"Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp","source_id_and_acronym":"NCT05638542","lead_sponsor":"Seoul National University Bundang Hospital","biomarkers":" EGFR • PD-L1 • KRAS • BRAF • TP53 • MSI • MLH1 • MSH6 • MSH2 • PMS2 • RUNX3 • IL1B • NLRP3 • NEUROG1 • CASP1","pipe":" | ","alterations":" PD-L1 expression • TP53 mutation • KRAS mutation • EGFR mutation • MSI-H/dMMR • BRAF mutation • EGFR expression • PMS2 mutation • TP53 expression • PD-L1 mutation","tags":["EGFR • PD-L1 • KRAS • BRAF • TP53 • MSI • MLH1 • MSH6 • MSH2 • PMS2 • RUNX3 • IL1B • NLRP3 • NEUROG1 • CASP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • TP53 mutation • KRAS mutation • EGFR mutation • MSI-H/dMMR • BRAF mutation • EGFR expression • PMS2 mutation • TP53 expression • PD-L1 mutation"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 582","initiation":"Initiation: 03/01/2015","start_date":" 03/01/2015","primary_txt":" Primary completion: 01/30/2021","primary_completion_date":" 01/30/2021","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2023-04-13"}]